암 환자의 한약-양약 상호작용에 대한 고찰

키워드

참고문헌 (44)

1. Mary Ann Richardson, "Biopharmacologic and Herbal Therapies for Cancer", J. Nutr, 131(11S), pp.3037~3040 (2001)
2. Cassileth BR, "Complementary and alternative therapies for cancer", Oncologist, 9(1), pp.80~89 (2004)
3. Ni H, "Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey", Med Care, 40(4), pp.353~358 (2002)
4. Meijerman I, "Herb-drug interactions in oncology: focus on mechanisms of induction", Oncologist, 11(7), pp.742~752 (2006)
5. "Information resource: About herbs, botanicals and other products"[URL]
6. Cassileth Lucarelli, "Herb-Drug Interactions in Oncology", pp.1~480 (2003), BC decker Inc.
7. 전국한의과대학 본초학교수, "본초학", pp.1~682 (2000), 영림사
8. 전국한의과대학 방제학교수, "방제학", pp.143~ (1999), 영림사
9. Herr SM, "Herb-Drug Interaction handbook" (2002), Church Street Books
10. Taussig SJ, "Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application", J Ethnopharmacol, 22(2), pp.191~202 (1988)
11. Ju YH, "Dietary genistein negates the inhibitory effects of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice", Can Res, 62(9), pp.2474~2477 (2002)
12. Upton, R., "Astragalus root: analytical, quality control and therapeutic monograph", American Herbal Pharmacopoeia, 1, pp.1~25 (1999)
13. Chu DT, "Fractionated extract of Astragalus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2", J Clin Lab Immunol, 26(4), pp.183~187 (1988)
14. Chu DT, "Immunotherapy with Chinese medicinal herbs. II. Reversal of Cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo", J Clin Lab Immunol, 25(3), pp.125~129 (1988)
15. Somasundaram S., "Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer", Cancer Res, 62(13), pp.3868~3875 (2002)
16. Ju YH, "Dietary genistein negates the inhibitory effects of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice", Can Res, 62(2), pp.2474~2477 (2002)
17. Liu B, "Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention", Cancer Res, 65(3), pp.879~886 (2005)
18. Mathijssen RHJ, "Effects of St. Johns wort on irinotecan metabolism", J Natl Cancer Inst, 94(16), pp.1247~1249 (2002)
19. Smith P, "The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate", Pharmacotherapy, 24(11), pp.1508~1514 (2004)
20. Frye RF, "Effect of St. John's wort on imatinib mesylate pharmacokinetics", Clin Pharmacol Ther, 76(4), pp.323~329 (2004)
21. Rubio IT, "Effect of glutamine on methotrexate efficacy and toxicity", Ann Surg, 227(5), pp.772~780 (1998)
22. Mason P., "Dietary Supplements" (2001), Pharmaceutical Press
23. Barrie R., "Cassileth, gary Deng. Complemwntary and Alternativw Therapies for Cancer", The Oncologist, 9(1), pp.80~89 (2004)
24. Weiger WA, "Advising patients who seek complementary and alternative medical therapies for cancer", Ann Intern Med, 137(11), pp.889~903 (2002)
25. Chrystal K, "The use of complementary", alternative medicine by cancer patients in a New Zealand regional cancer treatment centre, 2003, pp.116(1168), U296~
26. Eisenberg DM, "Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey", JAMA, 280(18), pp.1569~1575 (1998)
27. "Publication BFHC0462"[URL]
28. Ernst E, "The prevalence of complementary", alternative medicine in cancer: a systematic review, 1998, pp.83, 777~782
29. Pierce JP, "A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women’s Healthy Eating and Living (WHEL) Study", Control Clin Trials, 23(6), pp.728~756 (2002)
30. De Smet PA, "Clinical risk management of herb-drug interactions", Br J Clin Pharmacol, 63(3), pp.258~267 (2007)
31. AdrianeFugh-Berman, E. Ernst, "Herb-Drug interactions: Review and assessment of report reliability", 2001 Blackwell Science Ltd Br J Clin Pharmacol, 52, pp.587~595 (2001)
32. [URL]
33. "Complementary/integrative medicine"[URL]
34. "National Center for Complementary and Alternative Medicine"[URL]
35. "Office of Cancer Complementary and Alternative Medicine"[URL]
36. "Making treatment decisions: complementary and alternative therapies"[URL]
37. "Complementary and alternative medicine"[URL]
38. Ni H, "Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey", Med Care, 40(4), pp.353~358 (2002)
39. 김정선, "Natural Standard Methodology를 이용한 암 보완대체의학의 근거 및 권고수준에 대한 연구", 대한한방내과학회지, 29(1), pp.160~176 (2008), 대한한방내과학회
40. Meijerman I, "Herb-drug interactions in oncology: focus on mechanisms of induction", Oncologist, 11(7), pp.742~ (2006)
41. Meijerman I, "Herb -drug interactions in oncology: focus on mechanisms of induction", Oncologist, 11(7), pp.742~752 (2006)
42. 박재갑, "종양학", pp.140~174 (2003), 일조각
43. Izzo AA, "Interactions between herbal medicines and prescribed drugs: a systematic review", Drugs, 61, pp.2163~2175 (2001)
44. Fugh-Berman A., "Herb-drug interactions", Lancet, 355, pp.134~138 (2000)

관련 논문AI추천